Skip to content
ppharmaranks
Menu
Class IIOngoing

Ibuprofen Tablets recall

FDA recall D-0647-2024 · initiated Aug 8, 2024

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Sep 4, 2024How we research

Preferred Pharmaceuticals, Inc. recalled Ibuprofen Tablets in Aug 2024 — an FDA Class II recall (D-0647-2024) because Failed Impurities/Degradation Specifications - at 18-month Stability testing.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Impurities/Degradation Specifications - at 18-month Stability testing

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.

Quantity recalled: 266 bottles

Details

Product
Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories, Louisiana, Shreveport, NDC 68788-9110-03.
Recalling company
Preferred Pharmaceuticals, Inc.
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
CA and NV
Initiated
Aug 8, 2024
FDA report date
Sep 4, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Ibuprofen Tablets recalled?
Preferred Pharmaceuticals, Inc. recalled Ibuprofen Tablets in Aug 2024 — an FDA Class II recall (D-0647-2024) because Failed Impurities/Degradation Specifications - at 18-month Stability testing. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Ibuprofen Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0647-2024 was: Failed Impurities/Degradation Specifications - at 18-month Stability testing
Is a recalled Ibuprofen Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Ibuprofen Tablets are affected?
Distributed: CA and NV. The recall covers these lots — Lot: B0223H, Exp: 5/31/2026; C3023H, Exp: 9/30/2026.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0647-2024.

Source: openFDA Drug Enforcement record D-0647-2024

← All drug recalls